SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1513 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1142From X.ai: Dr. Pat Soon-Shiong@DrPatSoonShiong Sorry for the pause in Cancer DeEnd2War18/20/2025
1141Well, committing scarce resources to chase a long Covid treatment hasn’t seemed jargonweary68/19/2025
1140We agree with your analysis, and share your frustrations. We are hanging our habobbseytwins200128/18/2025
1139I am all for having a positive outlook on things in general, so I appreciate youluckydog8838/18/2025
1138I have to agree with Galt, and while that doesn't mean I fundamentally disagFitzhughlaw68/15/2025
1137PSS may be able to keep cash flow positive with his checking account (one of theOlecranon28/15/2025
1136Agree to disagree. I see a number of changes in PSS, having followed him for a galt48/15/2025
1135PSS is the multi-billionaire here in the IBRX story. Not only is he a brilliantbobbseytwins200128/15/2025
1134If PSS wanted to send a loud and clear message to the marketplace he would avoidgalt68/15/2025
1133The risk is dilution. With only limited current approvals for Anktiva, there is Olecranon28/15/2025
1132Come on guys! These people are trying to run a small biotech company, and they bobbseytwins200168/14/2025
1131I do agree that the Keystone Cops crew now at the FDA is a serious problem for ajargonweary28/14/2025
1130Absent some truly meteoric news or change in status, I remain pessimistic about Olecranon-8/14/2025
1129The lack of follow through today is as disappointing as it is unsurprisingjargonweary18/14/2025
1128From Xai x.comEnd2War-8/14/2025
1127New long covid trials. One already recruiting. clinicaltrials.gov clinicaltrimannamal-8/14/2025
1126D. Boral Capital Maintains Buy on ImmunityBio, Maintains $24 Price Target BENZINluckydog8828/14/2025
1125The Quilt-106 trial (NCT06334991, N=10) in SA does not include Anktiva. In the QHuggenberg28/14/2025
1124My question to Chat-GPT5 and its response: Question: Review this PR from IBEnd2War38/13/2025
1123Nice volume. Gotta work on that 77M short position …erippetoe18/13/2025
1122I could be wrong but I don’t think this trial involves anktiva fwiw. At least Ierippetoe-8/13/2025
1121I had also noted this a few days ago, and while it’s yet more validation of AnktFitzhughlaw48/13/2025
1120ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patieerippetoe58/13/2025
1119I find it significant that we're attending Bio-Europe in November. informacmannamal-8/13/2025
1118Oopsmannamal-8/13/2025
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News